
Ipamorelin Boosts Immune Function in HIV-Positive American Males: A Four-Year Study
Reading Time: 2 minutes Introduction The advent of antiretroviral therapy has significantly improved the prognosis for individuals living with HIV. However, the quest for adjunctive therapies that can further enhance immune function remains a critical area of research. Ipamorelin, a pentapeptide with growth hormone-releasing properties, has emerged as a potential candidate for improving immunological outcomes in American males with HIV. This article discusses a comprehensive four-year study that examines the effects of Ipamorelin on the immune system of HIV-positive American males, offering insights into its potential as an immune-enhancing agent. Study Design and Methodology The study was conducted over a four-year period, involving 150...